PMV Pharmaceuticals (PMVP) Profit After Tax (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Profit After Tax data on file, last reported at -$18.0 million in Q1 2026.

• Quarterly Profit After Tax fell 3.45% year-over-year to -$18.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78.3 million (down 28.62% YoY) and the FY2025 annual result came in at -$77.7 million, down 32.42% from the prior year.
• Profit After Tax was little changed at -$18.0 million in Q1 2026, from -$18.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$1.2 million in Q2 2024 to a low of -$23.0 million in Q4 2024.
• A 5-year average of -$17.5 million and a median of -$18.0 million in 2026 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax jumped 93.04% — and 2025, when it tumbled 1648.56%.
• Tracing PMVP's Profit After Tax over 5 years: stood at -$19.7 million in 2022, then rose by 20.07% to -$15.8 million in 2023, then tumbled by 45.98% to -$23.0 million in 2024, then grew by 21.79% to -$18.0 million in 2025, then decreased by 0.27% to -$18.0 million in 2026.
• The last three Profit After Tax figures came in at -$18.0 million (Q1 2026), -$18.0 million (Q4 2025), and -$21.1 million (Q3 2025), per Business Quant data.